cp wire

CP Wire Articles

  • Tango will receive $50 million up front
  • The company could receive up to $1.7 billion in additional payments
  • The partnership will focus on building a pipeline of novel immuno... read more
Wed, 10/31/18 - 09:34 am
  • 1 in 1000 women over the age of 40 lives with PBC
  • The company also has clinical trials underway for NASH

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced... read more

Tue, 10/30/18 - 10:23 am

Janssen Pharmaceutical today unveiled 96-week results from the pivotal Phase 3 AMBER study of Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide... read more

Tue, 10/30/18 - 09:53 am
  • Banyan BTI is the first test to aid in the diagnosis of concussion
  • The U.S. CDC estimates there are more than 2.5 million emergency room visits annually in the U.S. alone
... read more
Tue, 10/30/18 - 09:44 am
  • Larazotide is a tight junction regulator
  • The drug is also in Ph III trials for celiac disease
  • The FDA awarded fast track status to Larazotide for celiac
  • If approved... read more
Mon, 10/29/18 - 09:45 am
  • Framework may also help protect dementia patients
  • One researcher attributes Watson's failure in cancer diagnosis to a lack of emotion in the data

BPU Holdings... read more

Mon, 10/29/18 - 09:17 am
  • A dose-response relationship of increased gains in visual acuity (VA) was shown with ascending dose levels of OPT-302
  • OPT-302 is also being studied in wet AMD patients

... read more

Fri, 10/26/18 - 09:52 am

Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the successful closing of a €79 million series... read more

Fri, 10/26/18 - 09:37 am
  • Enterome will receive an upfront payment of $50 million end is eligible to receive up to $640 in additional payments
  • Enterome and Takeda also have agreements targeting multiple other... read more
Thu, 10/25/18 - 12:41 pm
  • The neural stem cell line into APP/PS1 mice that carry genes bearing mutations associated with onset of AD in humans
  • NSI-532.IGF1 is a second-generation cell therapy candidate that... read more
Thu, 10/25/18 - 09:48 am
  • The FDA previously granted ruxolitinib Breakthrough Therapy Designation for the treatment of acute GVHD
  • Jakafi is marketed by Incyte in the United States and by Novartis as Jakavi (... read more
Thu, 10/25/18 - 09:33 am
  • Xofluxa is a single-dose one-time treatment compared to Tamiflu's twice daily for five day regimen
  • In two trials, patients taking Xofluxa had a shorter duration of flu symptoms... read more
Wed, 10/24/18 - 12:39 pm
The 18th Annual Temperature Controlled Logistics Conference will bring together supply chain, logistics and quality experts from around the globe to experience four days of ‘unmissable’... read more
Wed, 10/24/18 - 12:30 pm
  • Zanubrutinib demonstrated a high overall response rate of 80 percent
  • Zanubrutinib was recently granted Fast Track Designation by the US FDA for Waldenström macroglobulinemia (WM)... read more
Wed, 10/24/18 - 11:53 am
  • 60.3% of all randomised ustekinumab-treated patients who entered the long-term extension study were in clinical remission at week 152
  • Of those patients who were naïve to TNF... read more
Wed, 10/24/18 - 09:45 am

TP Therapeutics announced on 10/24/18 a global collaboration agreement to develop and commercialize a next-generation sequencing (NGS) companion diagnostic (CDx) for repotrectinib, TP... read more

Wed, 10/24/18 - 09:30 am
  • Bain Capital committed $350 million to the company
  • Pfizer is contributing a portfolio of assets that includes three clinical-stage compounds

Bain Capital, LP and... read more

Tue, 10/23/18 - 10:14 am
  • OMS721 also has orphan status for two other conditions
  • OMS721 is Omeros’ lead human MASP-2 antibody
  • The drug was awarded fast track designation for the treatment of patients... read more
Tue, 10/23/18 - 09:43 am
  • Glucagon is the standard of care for treating severe hypoglycemia
  • Mild to moderate hypoglycemia occurs monthly and severe hypoglycemia can occur several times per year
  • The... read more
Tue, 10/23/18 - 09:24 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.